Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases
Michael D. Schwartz, Juan J. Canales, Riccardo Zucchi, et al.
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 6, pp. 513-526
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia
Kenneth S. Koblan, Justine Kent, Seth C. Hopkins, et al.
New England Journal of Medicine (2020) Vol. 382, Iss. 16, pp. 1497-1506
Open Access | Times Cited: 245
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2Receptor Mechanism of Action
Nina Dedic, Philip Jones, Seth C. Hopkins, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 371, Iss. 1, pp. 1-14
Open Access | Times Cited: 151
Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities
Amanda Krogmann, Luisa Peters, Laura von Hardenberg, et al.
CNS Spectrums (2019) Vol. 24, Iss. S1, pp. 38-69
Open Access | Times Cited: 103
Mechanism of Action of Atypical Antipsychotic Drugs in Mood Disorders
Daniil Grinchii, Eliyahu Dremencov
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9532-9532
Open Access | Times Cited: 79
Pharmacology of Drugs Used as Stimulants
James R. Docherty, Hadeel A. Alsufyani
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 64
Structural and signaling mechanisms of TAAR1 enabled preferential agonist design
Pan Shang, Naikang Rong, Jingjing Jiang, et al.
Cell (2023) Vol. 186, Iss. 24, pp. 5347-5362.e24
Open Access | Times Cited: 27
TAAR Agonists
Zhengrong Xu, Qian Li
Cellular and Molecular Neurobiology (2019) Vol. 40, Iss. 2, pp. 257-272
Closed Access | Times Cited: 43
Regulation of Glutamate, GABA and Dopamine Transporter Uptake, Surface Mobility and Expression
Renae M. Ryan, Susan Ingram, Annalisa Scimemi
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 39
New Antipsychotic Medications in the Last Decade
Mehak Pahwa, Ahmad Sleem, Omar H. Elsayed, et al.
Current Psychiatry Reports (2021) Vol. 23, Iss. 12
Closed Access | Times Cited: 34
Novel Molecular Targets of Antidepressants
Małgorzata Jarończyk, Jarosław Walory
Molecules (2022) Vol. 27, Iss. 2, pp. 533-533
Open Access | Times Cited: 24
Molecular Variants in Human Trace Amine-Associated Receptors and Their Implications in Mental and Metabolic Disorders
Grazia Rutigliano, Riccardo Zucchi
Cellular and Molecular Neurobiology (2019) Vol. 40, Iss. 2, pp. 239-255
Open Access | Times Cited: 41
Actions of Trace Amines in the Brain-Gut-Microbiome Axis via Trace Amine-Associated Receptor-1 (TAAR1)
Katlynn Bugda Gwilt, Pamela González-Dávila, Neva Olliffe, et al.
Cellular and Molecular Neurobiology (2019) Vol. 40, Iss. 2, pp. 191-201
Closed Access | Times Cited: 40
Effect of TAAR1/5-HT1A agonist SEP-363856 on REM sleep in humans
Seth C. Hopkins, Nina Dedic, Kenneth S. Koblan
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders
Savelii R. Kuvarzin, Ilya Sukhanov, Kirill Onokhin, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1977-1977
Open Access | Times Cited: 11
T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line
Beatrice Polini, Caterina Ricardi, A Bertolini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11569-11569
Open Access | Times Cited: 11
TAARs as Novel Therapeutic Targets for the Treatment of Depression: A Narrative Review of the Interconnection with Monoamines and Adult Neurogenesis
Taisiia S. Shemiakova, Evgeniya V. Efimova, Raul R. Gainetdinov
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1263-1263
Open Access | Times Cited: 4
Role of trace amine‑associated receptor 1 in the medial prefrontal cortex in chronic social stress-induced cognitive deficits in mice
Yue Zhang, Jitao Li, Han Wang, et al.
Pharmacological Research (2021) Vol. 167, pp. 105571-105571
Closed Access | Times Cited: 26
Population pharmacokinetic analysis of ulotaront in subjects with schizophrenia
Gerald R. Galluppi, Daniel Polhamus, Jeannine M. Fisher, et al.
CPT Pharmacometrics & Systems Pharmacology (2021) Vol. 10, Iss. 10, pp. 1245-1254
Open Access | Times Cited: 25
Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis
Serge Nataf, Laurent Pays
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10440-10440
Open Access | Times Cited: 24
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia
Andrea de Bartolomeis, Mariateresa Ciccarelli, Licia Vellucci, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 18, pp. 2035-2052
Closed Access | Times Cited: 17
Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies
Valeria Francesconi, Elena Cichero, Evgeny Kanov, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 11, pp. 391-391
Open Access | Times Cited: 25
Mechanism of Action of Atypical Antipsychotic Drugs in Mood Disorders
Daniil Grinchii, Eliyahu Dremencov
(2020)
Open Access | Times Cited: 24
Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity
Alice Accorroni, Grazia Rutigliano, Martina Sabatini, et al.
Thyroid (2019) Vol. 30, Iss. 1, pp. 147-160
Open Access | Times Cited: 24
Identification of a Potent Human Trace Amine-Associated Receptor 1 Antagonist
Ann M. Decker, Marcus F. Brackeen, Aida Mohammadkhani, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 7, pp. 1082-1095
Open Access | Times Cited: 13
Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia
Andrea de Bartolomeis, Mariateresa Ciccarelli, Giuseppe De Simone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5945-5945
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top